Delivery Order SPE2DB20D3103-SPE2DB24FN5U9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,301.44 firm fixed-price delivery order covers the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,323.65 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent certain types of blood clots. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,089.90 Firm Fixed Price Delivery Order contract is for the supply of Eliquis 5 mg tablets, a prescription medication used to treat and prevent blood clots. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,322.96 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which runs through November 2026. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,268.63 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,798.98 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,151.75 fixed-price delivery order is for the provision of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,068.06 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract is not designated with a set-aside and was awarded under an Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $12,249.37 firm-fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,129.73 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a period of performance through May 9, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN5U9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,730.33 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999 and running through November 2026. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this award, indicating open competition. Amerisourcebergen is a critical vendor for federal healthcare programs, particularly within the Department of Defense (DoD) and Department of Veterans Affairs (VA), leveraging its extensive supply chain and distribution capabilities to deliver essential medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 4/25/24 |